Symbol List Views
Stock Details
CHARTS
COMPANY NEWS
STOCK ANALYSIS
FUNDAMENTALS
HOLDINGS
Edit Symbol List
Symbol Lookup
NUVA: Stock Quote & Summary Data
9.02%
| Last Sale | |
| Change Net / % |
|
| Best Bid / Ask | |
| 1y Target Est: | N/A |
| Today's High / Low | / |
| Share Volume | |
| 50 Day Avg. Daily Volume | 722,031 |
| Previous Close | $ 37.15 |
| 52 Wk High / Low | $ 45.06 / $ 24.17 |
| Shares Outstanding | 38,218,000 |
| Market Value | $ 1,291,768,400 |
| Annualized Dividend | N/A |
| Ex Dividend Date | N/A |
| Dividend Payment Date | N/A |
| Current Yield | N/A |
| Beta | 1.07 |
| NASDAQ Official Open Price: | $ 36.85 |
| Date of NASDAQ Official Open Price: | Nov. 20, 2009 |
| NASDAQ Official Close Price: | $ 33.80 |
| Date of NASDAQ Official Close Price: | Nov. 20, 2009 |
Intraday Chart |
| 5d | 1m | 6m | 12m | More Charting |
Have a Question About NUVA?
Ask your question about about NuVasive, Inc. (NUVA) by typing it in the box below. You'll get direct responses from other members of the NASDAQ Answers community!
Hot Topics in NASDAQ Answers
The most popular questions & answers in the
NASDAQ Answers Community:
Company Description (as filed with the SEC)
We are a medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders. Our currently-marketed product portfolio is focused on applications for spine fusion surgery, a market estimated to exceed $4.2 billion in the United States in 2008. Our principal product offering includes a minimally disruptive surgical platform called Maximum Access Surgery, or MAStm, as well as a growing offering of cervical and motion preservation products. Our currently-marketed products are used predominantly in spine fusion surgeries, both to enable access to the spine and to perform restorative and fusion procedures. ... More ...
Links to all NuVasive, Inc. (NUVA) Pages
Stock Analysis
Fundamentals
Holdings/Ownership
Company News for NUVA |
||
|
NuVasive Inc. Has Fallen To A 6-Month Low - RTT News 11/20/2009 10:53AM |
||
|
NuVasive Names Michael Lambert CFO - Update - RTT News 11/06/2009 11:20AM |
||
|
NuVasive Appoints Michael Lambert As EVP And CFO, Effective Nov. 9 - Quick Facts - RTT News 11/06/2009 9:09AM |
||
|
NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates - PR Newswire 11/06/2009 8:30AM |
||
|
NuVasive to Host Investor Luncheon on November 11, 2009 - PR Newswire 11/04/2009 4:30PM |
||
|
AnalystChoice.com Gives Technical review on ARTG, BEAV, NUVA, ACAS, CEDC and AVNR - Market Wire 11/04/2009 5:34AM |
||
|
NuVasive Closed At Over Five-Month Low Monday - RTT News 11/03/2009 8:49AM |
